BACKGROUND: The prevalence in the United States of dietary supplement use that may be harmful to those with chronic kidney disease (CKD) is unknown. We sought to characterize potentially harmful supplement use by individual CKD status. STUDY DESIGN: Cross-sectional national survey (National Health and Nutrition Examination Survey, 1999-2008). SETTING & PARTICIPANTS: Community-based survey of 21,169 nonpregnant noninstitutionalized US civilian adults (aged ≥20 years). PREDICTOR: CKD status (no CKD, at risk of CKD [presence of diabetes, hypertension, and/or cardiovascular disease], stages 1/2 [albuminuria only (albumin-creatinine ratio ≥30 mg/g)], or stages 3/4 [estimated glomerular filtration rate of 15-59 mL/min/1.73 m(2)]). OUTCOME: Self-reported use of dietary supplements containing any of 37 herbs the National Kidney Foundation identified as potentially harmful in the setting of CKD. MEASUREMENTS: Albuminuria and estimated glomerular filtration rate assessed from urine and blood samples; demographics and comorbid conditions assessed by standardized questionnaire. RESULTS: An estimated 8.0% of US adults reported potentially harmful supplement use within the last 30 days. A lower crude estimated prevalence of potentially harmful supplement use was associated with higher CKD severity (no CKD, 8.5%; at risk, 8.0%; stages 1/2, 6.1%; and stages 3/4, 6.2%; P < 0.001). However, after adjustment for confounders, those with or at risk of CKD were as likely to use a potentially harmful supplement as those without CKD: at-risk OR, 0.93 (95% CI, 0.79-1.09); stages 1/2 OR, 0.83 (95% CI, 0.64-1.08); and stages 3/4 OR, 0.87 (95% CI, 0.63-1.18); all versus no CKD. LIMITATIONS: Herb content was not available and the list of potentially harmful supplements examined is unlikely to be exhaustive. CONCLUSIONS: The use of dietary supplements potentially harmful to people with CKD is common regardless of CKD status. Health care providers should discuss the use and potential risks of supplements with patients with and at risk of CKD.
RCT Entities:
BACKGROUND: The prevalence in the United States of dietary supplement use that may be harmful to those with chronic kidney disease (CKD) is unknown. We sought to characterize potentially harmful supplement use by individual CKD status. STUDY DESIGN: Cross-sectional national survey (National Health and Nutrition Examination Survey, 1999-2008). SETTING & PARTICIPANTS: Community-based survey of 21,169 nonpregnant noninstitutionalized US civilian adults (aged ≥20 years). PREDICTOR: CKD status (no CKD, at risk of CKD [presence of diabetes, hypertension, and/or cardiovascular disease], stages 1/2 [albuminuria only (albumin-creatinine ratio ≥30 mg/g)], or stages 3/4 [estimated glomerular filtration rate of 15-59 mL/min/1.73 m(2)]). OUTCOME: Self-reported use of dietary supplements containing any of 37 herbs the National Kidney Foundation identified as potentially harmful in the setting of CKD. MEASUREMENTS: Albuminuria and estimated glomerular filtration rate assessed from urine and blood samples; demographics and comorbid conditions assessed by standardized questionnaire. RESULTS: An estimated 8.0% of US adults reported potentially harmful supplement use within the last 30 days. A lower crude estimated prevalence of potentially harmful supplement use was associated with higher CKD severity (no CKD, 8.5%; at risk, 8.0%; stages 1/2, 6.1%; and stages 3/4, 6.2%; P < 0.001). However, after adjustment for confounders, those with or at risk of CKD were as likely to use a potentially harmful supplement as those without CKD: at-risk OR, 0.93 (95% CI, 0.79-1.09); stages 1/2 OR, 0.83 (95% CI, 0.64-1.08); and stages 3/4 OR, 0.87 (95% CI, 0.63-1.18); all versus no CKD. LIMITATIONS: Herb content was not available and the list of potentially harmful supplements examined is unlikely to be exhaustive. CONCLUSIONS: The use of dietary supplements potentially harmful to people with CKD is common regardless of CKD status. Health care providers should discuss the use and potential risks of supplements with patients with and at risk of CKD.
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Jane Marsh; Lesley A Stevens; John W Kusek; Frederick Van Lente Journal: Clin Chem Date: 2007-03-01 Impact factor: 8.327
Authors: Katherine Gooch; Bruce F Culleton; Braden J Manns; Jianguo Zhang; Helman Alfonso; Marcello Tonelli; Cy Frank; Scott Klarenbach; Brenda R Hemmelgarn Journal: Am J Med Date: 2007-03 Impact factor: 4.965
Authors: Alexander G Schauss; Xianli Wu; Ronald L Prior; Boxin Ou; Dejian Huang; John Owens; Amit Agarwal; Gitte S Jensen; Aaron N Hart; Edward Shanbrom Journal: J Agric Food Chem Date: 2006-11-01 Impact factor: 5.279
Authors: Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey Journal: JAMA Date: 2007-11-07 Impact factor: 56.272
Authors: J L Vanherweghem; M Depierreux; C Tielemans; D Abramowicz; M Dratwa; M Jadoul; C Richard; D Vandervelde; D Verbeelen; R Vanhaelen-Fastre Journal: Lancet Date: 1993-02-13 Impact factor: 79.321
Authors: Elizabeth Selvin; Jane Manzi; Lesley A Stevens; Frederick Van Lente; David A Lacher; Andrew S Levey; Josef Coresh Journal: Am J Kidney Dis Date: 2007-12 Impact factor: 8.860
Authors: Paul E Drawz; Patrick Archdeacon; Clement J McDonald; Neil R Powe; Kimberly A Smith; Jenna Norton; Desmond E Williams; Uptal D Patel; Andrew Narva Journal: Clin J Am Soc Nephrol Date: 2015-06-25 Impact factor: 8.237
Authors: Carmen Loquai; Dagmar Dechent; Marlene Garzarolli; Martin Kaatz; Katharina C Kaehler; Peter Kurschat; Frank Meiss; Annette Stein; Dorothee Nashan; Oliver Micke; Ralph Muecke; Karsten Muenstedt; Christoph Stoll; Irene Schmidtmann; Jutta Huebner Journal: Med Oncol Date: 2016-04-18 Impact factor: 3.064
Authors: Deidra C Crews; Marie Fanelli Kuczmarski; Edgar R Miller; Alan B Zonderman; Michele K Evans; Neil R Powe Journal: J Ren Nutr Date: 2014-09-17 Impact factor: 3.655
Authors: Shaheen Kurani; LaTonya J Hickson; Bjorg Thorsteinsdottir; Erin F Barreto; Jordan D Haag; Nilay D Shah; Rozalina G McCoy Journal: Am J Kidney Dis Date: 2019-07-18 Impact factor: 8.860
Authors: Yang Liu; Marie Fanelli Kuczmarski; Edgar R Miller; M Berenice Nava; Alan B Zonderman; Michele K Evans; Neil R Powe; Deidra C Crews Journal: J Ren Nutr Date: 2016-10-19 Impact factor: 3.655
Authors: Delphine S Tuot; Karen K Wong; Alexandra Velasquez; Deidra C Crews; Alan B Zonderman; Michele K Evans; Neil R Powe Journal: Kidney Med Date: 2019-02-25